Article Details

Biotechnology: Acquisition of a company with Greek roots for $1.7 billion

Retrieved on: 2025-05-02 13:18:44

Tags for this article:

Click the tags to see associated articles and topics

Biotechnology: Acquisition of a company with Greek roots for $1.7 billion. View article details on hiswai:

Summary

The article details Novartis's acquisition of Regulus Therapeutics, emphasizing the role of Greek founders and venture capital investors in expanding RNA technology innovations. It highlights the significance of the venture capital fund, Kos Biotechnology Partners, in supporting Greek biotech ventures.

Article found on: en.protothema.gr

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo